The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three-item severity score
Abstract
It is important to determine the severity of atopic dermatitis (AD) for evaluation of disease improvement after and during therapy. Scoring of the severity of AD is demanded in clinical trials. The European Task Force on Atopic Dermatitis (ETFAD) has developed the SCORAD (SCORing AD) index to create a consensus on assessment methods for AD, so that study results of different trials can be compared. However, modification of the SCORAD index has led on several occasions to wrong and incorrect use of the system. To measure the extent of AD, the rule of nines is applied on a front/back drawing of the patient's inflammatory lesions. The extent can be graded 0-100. The intensity part of the SCORAD index consists of six items: erythema, oedema/papulation, excoriations, lichenification, oozing/crusts and dryness. Each item can be graded on a scale 0-3. The subjective items include daily pruritus and sleeplessness. Both subjective items can be graded on a 10-cm visual analogue scale. The maximum subjective score is 20. All items should be filled out in the SCORAD evaluation form. The SCORAD index formula is: A/5 + 7B/2 + C. In this formula A is defined as the extent (0-100), B is defined as the intensity (0-18) and C is defined as the subjective symptoms (0-20). The maximum SCORAD score is 103. Based on training sessions by the ETFAD, the SCORAD index was modified by excluding the subjective symptoms (objective SCORAD). The objective SCORAD consists of just the extent and intensity items, the formula being A/5 + 7B/2. The maximum objective SCORAD score is 83 (plus an additional 10 bonus points). Bonus points are given for severe disfiguring eczema (on face and hands). The three-item severity (TIS) score involves the scoring of erythema (redness), oedema and excoriations (scratches) in one representative lesion, marked as R-O-S. The TIS score corresponds well with the more detailed objective SCORAD and can be used as a prescreening system or as a quick system in studies and is excellent for epidemiological studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic features of atopic dermatitis
Hanifin, J. M., & Rajka, G. (1980) · Acta Dermato-Venereologica · doi:10.2340/00015555924447 · Cited by 5,086
Severity Scoring of Atopic Dermatitis: The SCORAD Index
(2009) · Dermatology · doi:10.1159/000247298 · Cited by 2,273
WILLIAMS, H. C., JBURNEY, P. G., HAY, R. J., ARCHER, C. B., SHIPLEY, M. J., AHUNTER, J. J., BINGHAM, E. A., FINLAY, A. Y., PEMBROKE, A. C., CGRAHAM-BROWN, R. A., et al. (1994) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1994.tb08530.x · Cited by 1,271
Kunz, B., Oranje, A. P., Labrèze, L., Stalder, J.-F., Ring, J., & Taïeb, A. (1997) · Dermatology · doi:10.1159/000245677 · Cited by 1,046
Self-citationBERTH-JONES, J. (1996) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1996.tb00706.x · Cited by 191
Wolkerstorfer, F. B. D. W. V. D. (1999) · Acta Dermato-Venereologica · doi:10.1080/000155599750010256 · Cited by 161
Charman, C., Chambers, C., & Williams, H. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12251.x · Cited by 160
Barbier, N., Paul, C. F., Luger, T. A., Allen, R., Prost, Y. D., Papp, K. A., Eichenfield, L. F., Cherill, R., & Hanifin, J. M. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.05696.x · Cited by 154
Sampson, H. A. (1990) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1990.tb03137.x · Cited by 127
Oranje, A. P., Stalder, J. ‐., Taı̈eb, A., Tasset, C. T., & Longueville, M. D. (1997) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.1997.tb00139.x · Cited by 109
Self-citation
Cited by
Kong, H. H., Oh, J., Deming, C., Conlan, S., Grice, E. A., Beatson, M. A., Nomicos, E., Polley, E. C., Komarow, H. D., Program, N. C. S., et al. (2012) · Genome Research · doi:10.1101/gr.131029.111 · Cited by 1,808
Suárez-Fariñas, M., Tintle, S. J., Shemer, A., Chiricozzi, A., Nograles, K., Cardinale, I., Duan, S., Bowcock, A. M., Krueger, J. G., & Guttman-Yassky, E. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.12.1124 · Cited by 464
Atopic dermatitis yardstick: Practical recommendations for an evolving therapeutic landscape
Boguniewicz, M., Fonacier, L., Guttman-Yassky, E., Ong, P. Y., Silverberg, J., & Farrar, J. R. (2018) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2017.10.039 · Cited by 305
The altered landscape of the human skin microbiome in patients with primary immunodeficiencies
Oh, J., Freeman, A. F., Program, N. C. S., Park, M., Sokolic, R., Candotti, F., Holland, S. M., Segre, J. A., & Kong, H. H. (2013) · Genome Research · doi:10.1101/gr.159467.113 · Cited by 282
A randomized trial of methotrexate versus azathioprine for severe atopic eczema
Schram, M. E., Roekevisch, E., Leeflang, M. M. G., Bos, J. D., Schmitt, J., & Spuls, P. I. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.03.024 · Cited by 260
Metadata
- Authors
- Oranje, A. P., Glazenburg, E. J., Wolkerstorfer, A., & de Waard-van der Spek, F. B.
- Venue
- British Journal of Dermatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-10
- Volume
- 157
- Issue
- 4
- Pages
- 645-648
- ISSN
- 0007-0963 (ISSN-L)
- 1365-2133
- OpenAlex
- W2116158190
- Cited by
- 471
- References
- 14
- FWCI
- 16.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three-item severity score. https://app.cochat.ai/papers/10.1111/j.1365-2133.2007.08112.x
- The paper
- Oranje, A. P., Glazenburg, E. J., Wolkerstorfer, A., & de Waard-van der Spek, F. B. (2007). Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three-item severity score. British Journal of Dermatology. https://doi.org/10.1111/j.1365-2133.2007.08112.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.